NEW YORK, NY / ACCESSWIRE / January 31, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Talis Biomedical Corporation (NASDAQ:TLIS)
CONTACT JAKUBOWITZ ABOUT TLIS :
https://claimyourloss.com/securities/talis-biomedical-corporation-loss-submission-form/?id=22718&from=1
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's February 2021 initial public offering.
Lead Plaintiff Deadline : March 8, 2022
According to the lawsuit, documents that the Company issued in connection with its IPO failed to disclose to investors: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis's Emergency Use Authorization application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test; (3) that, as a result, the Company's commercialization timeline would be significantly delayed; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
First Solar, Inc. (NASDAQ:FSLR)
CONTACT JAKUBOWITZ ABOUT FSLR :
https://claimyourloss.com/securities/first-solar-inc-loss-submission-form/?id=22718&from=1
This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired shares of First Solar common stock between February 22, 2019, and February 20, 2020, inclusive.
Lead Plaintiff Deadline : March 8, 2022
According to the filed complaint, defendants made repeated misrepresentations to investors regarding the development of First Solar's newest "Series 6" solar module, the cost per unit it could achieve with that module, and the impact the changeover to this new product would have on the viability of its other business segments. As a result of defendants' misrepresentations, First Solar common stock traded at artificially inflated prices during the class period.
Clarivate Plc (NYSE:CLVT)
CONTACT JAKUBOWITZ ABOUT CLVT :
https://claimyourloss.com/securities/clarivate-plc-loss-submission-form/?id=22718&from=1
Class Period: February 26, 2021 - December 27, 2021
Lead Plaintiff Deadline : March 25, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Clarivate maintained defective disclosure controls and procedures as a result of a material weakness in its internal control over financial reporting; (ii) the foregoing material weakness was not limited to how the Company accounted for warrants; (iii) as a result, Clarivate failed to properly account for an equity plan included in its acquisition of CPA Global, a global leader in Intellectual Property software and tech-enabled services; (iv) accordingly, the Company was reasonably likely to restate one or more of its previously issued financial statements following its acquisition of CPA Global; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE : Jakubowitz Law